1Y Annualised Return
▲116.96%
3Y Annualised Return
▲87.89%
5Y Annualised Return
▲66.58%
10Y Annualised Return
▲19.87%
Novelix Pharmaceuticals Stock Performance
|
|
|
Novelix Pharmaceuticals Company background
Founded in: 1994
Novelix Pharmaceuticals Limited was initially incorporated as Trimurthi Securities Limited on December 13, 1994. The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drugs Pharmaceuticals Limited. Also, the name of the Company was changed to Trimurthi Drugs Pharmaceuticals Limited and again to Trimurthi Limited in May, 2016. The Company has altered the name to Novelix Pharmaceuticals Limited in 2025. Initially, the company was engaged in finance and investments in securities. They ceased their operations due to the high volatility in the markets and voluntarily got deregistered as NonBanking financial company. Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs Pharmaceuticals Ltd amalgamated with the Company.In November 2009, the Company received NSEN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from Kvalitet Veritas Quality Assurance. They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh.During the year 201011, the Company started their first Pharmacy Retail Outlet in Himayath Nagar, Hyderabad. Also, they started their second retail outlet at Inderbagh, Sultan Bazar, Hyderabad. The Company with its full capacity commenced the business operations in food industry business through its wholly owned subsidiary in 2018.The Company started their operations in State of West Bengal. Also, they started marketing of their products in Assam and with that they marked their presence in the eastern part of India.The Company has been acquired by the new Promoter SrinidhiFine Chemicals LLP and others through open offer under the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in FY202425. During the year 202425, Company has entered in the business of Manufacturing / Trading of Pharmaceuticals and Pharmaceutical Intermediates (Bulk drugs), and in and in Healthcare Research, Analytics Technology.
Novelix Pharmaceuticals Financial Highlights
For the full year FY2022–2023, revenue
reached ₹9.16 crore and profit touched at
₹-2.11 crore.
Novelix Pharmaceuticals Share Price Today
As of 7 Mar 2026, Novelix Pharmaceuticals share price is ₹56. The stock opened at ₹55 and had closed at ₹55 the previous day. During today’s trading session, Novelix Pharmaceuticals share price moved between ₹55.00 and ₹58.99, with an average price for the day of ₹57.00. Over the last 52 weeks, the stock has recorded a low of ₹25.35 and a high of ₹70.16. In terms of performance, Novelix Pharmaceuticals share price has increased by 43.6% over the past six months and has increased by 116.96% over the last year.
Novelix Pharmaceuticals SIP Return Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹23,33,402 in 5 years with a gain of ₹20,33,402 (+677.80%)

View details of Market Depth
Novelix Pharmaceuticals Fundamental
Market Cap (in crs)
111.66
Face Value
10
Turnover (in lacs)
0.91
Key Metrics
Qtr Change %
120.95% Gain from 52W Low
-1.3
Dividend yield 1yr %
0
Novelix Pharmaceuticals Key Financials
View moreLoading chart...
Novelix Pharmaceuticals Quarterly Revenue
1.24 Cr | 1.36 Cr | 0.69 Cr | 1.11 Cr | 2.46 Cr |
Novelix Pharmaceuticals Yearly Revenue
9.16 Cr | 9.59 Cr | 10.85 Cr | 10.84 Cr | 10.71 Cr | 9.35 Cr |
Novelix Pharmaceuticals Quarterly Net Profit/Loss
-0.14 Cr | -0.11 Cr | -1.6 Cr | -0.7 Cr | 0.35 Cr |
Novelix Pharmaceuticals Yearly Net Profit/Loss
-2.11 Cr | -3.74 Cr | -0.26 Cr | -0.15 Cr | -0.35 Cr | 0.03 Cr |
Novelix Pharmaceuticals Technical Analysis
Moving Averages Analysis
56.01
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
Day EMA5
56.80
Day EMA10
58.30
Day EMA12
58.70
Day EMA20
59.40
Day EMA26
59.60
Day EMA50
59.00
Day EMA100
55.70
Day EMA200
47.60
Delivery & Volume
Loading chart...
Delivery Volume %
Day
93.90%
Week
78.90%
Month
81.40%
Delivery & Volume
Day Rs | 1533 Rs | 1632 Rs |
Week Rs | 4107 Rs | 5205 Rs |
Month Rs | 4893 Rs | 6010 Rs |
Resistance & Support
56.67
Pivot
Resistance
First Resistance
58.33
Second Resistance
60.66
Third Resistance
62.32
Support
First Support
54.34
Second support
52.68
Third Support
50.35
Relative Strength Index
40.23
Money Flow Index
53.04
MACD
-0.90
MACD Signal
0.02
Average True Range
3.78
Average Directional Index
16.56
Rate of Change (21)
-8.45
Rate of Change (125)
41.26
Novelix Pharmaceuticals Peer comparison
Compare14.72 +0.25 (+1.73%)▲ | |
204.95 0.00 (0.00%)▼ | |
6.62 -0.25 (-3.64%)▼ | |
117.05 0.00 (0.00%)▼ | |
78.00 +2.85 (+3.79%)▲ | |
66.50 (0.00%)▼ |
Novelix Pharmaceuticals Latest News
View More
Novelix Pharmaceuticals Share Price FAQs
Please be aware that Novelix Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.